After 12 weeks, there was a substantial 52% decrease in red, inflammatory acne spots and a 46% reduction in non-red spots
Considering that approximately 40 percent of people with type 2 diabetes have chronic kidney disease, Lange stated, based on data from the Phase III FLOW trial
An important societal question is access equity
With an estimated 2.5 million people already using weight-loss injections in the UK, we should expect demand for weight-loss pills to be incredibly high and be a major foundation for tackling the obesity crisis. Katharine Jenner, executive director of the Obesity Health Alliance, said on Thursday: An oral Wegovy pill could help widen access to effective treatment, especially if it is cheaper and easier for patients to use
Concurrent diabetes medications often require dose reductions when starting or escalating tirzepatide
While food timing is not a medical requirement for most GLP-1 injections, establishing a consistent routine optimizes treatment outcomes and minimizes the risk of missed doses
